project id: TCGA-CESC; case submitter id: TCGA-EK-A2RD; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.8; rna integrity number: 4.6; age at index: 47; days to birth: -17191; ethnicity: not hispanic or latino; gender: female; race: american indian or alaska native; vital status: Alive; year of birth: 1962; age at diagnosis: 17191; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2.0; figo stage: Stage IB1; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 658; initial weight: 120.0; oct embedded: false; preservation method: Unknown; sample id: 5690a425-ba49-4bca-b5ec-461bd5660be0; sample submitter id: TCGA-EK-A2RD-01A; portion id: b29d029e-7b93-47be-a89e-515ed26fbfb2; portion submitter id: TCGA-EK-A2RD-01A-12; slide id: 2b7f6e30-3a34-4193-afff-c62693ffbdcd; slide submitter id: TCGA-EK-A2RD-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 13.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; section location: TOP;